Nasal Covaxin phase II & III trials to focus on remote areas – ET HealthWorld

NAGPUR: After getting the final nod from the Drug Controller General of India (DCGI) for the second and third phase trials of the nasal Covaxin, Bharat Biotech Ltd will launch nationwide trials with Nagpur being one of the sites. The government medical college and hospital (GMCH) is likely to host the trials, said sources. The GMCH is yet to receive the formal confirmation, but it fulfils the necessary criteria. The first phase of the nasal Covaxine was held at Gillurkar Multispecialty Hospital in Nagpur where volunteers were mostly from the…

Read More